Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 521 record(s)

Req # A-2020-00043

Total number of senior management employees approved for private language lessons less than five years away from their retirement date between January 1, 2015 and August 26, 2020.

Organization: Canada Economic Development for Quebec Regions

1 page(s)
September 2020

Req # A-2020-00047

Briefing documents and correspondence concerning the $300,000 repayable contribution to Group WYM , announced August on 27, 2020.

Organization: Canada Economic Development for Quebec Regions

4 page(s)
September 2020

Req # A-2020-00052

Total amount of expenses incurred between March 1, 2020 and September 14, 2020, with regards to the 2020/2021 object codes 1231, 1246, and 0533.

Organization: Canada Economic Development for Quebec Regions

2 page(s)
September 2020

Req # 2340-600

As part of the Request for Proposals 62652 / Champlain Bridge, design-build services for the deconstruction of the original Champlain Bridge (2019-2023), an electronic copy of the following documents: •The Proposal – Financial Soundness and Technical Compliance Component of the Preferred Proponent; •The Proposal – Technical Qualitative Valuation Component of the Preferred Proponent; •The Proposal – Price Component of the Preferred Proponent; •Any document in JCCBI’s possession relating to the compliance of the Proposals received under the Request for Proposals; •All reports analyzing the conformity of Proposals, either internal or received from Consultants or externals firms ; •Any decision from JCCBI, the Evaluation Committee or any other person deciding for the purposes of the Procurement Process relating to the conformity of the Proposals as well as any document related to these decisions. •Any correspondence or exchange of information with the Preferred Proponent since the filing of Proposals.

Organization: Jacques Cartier and Champlain Bridges Incorporated

3230 page(s)
September 2020

Req # A-2020-00004

List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.

Organization: Patented Medicine Prices Review Board Canada

4 page(s)
September 2020

Req # A-2020-04135

Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

79 page(s)
September 2020

Req # A-2020-09098

Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
September 2020

Nothing to report this month

Organization: Canadian Air Transport Security Authority

September 2020

Nothing to report this month

Organization: Defence Construction Canada

September 2020

Nothing to report this month

Organization: First Nations Tax Commission

September 2020
Date modified: